+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Control of albuminuria in overt diabetic nephropathy: durability counts



Control of albuminuria in overt diabetic nephropathy: durability counts



Nephrology, Dialysis, Transplantation 31(9): 1371-1373




(PDF emailed within 0-6 h: $19.90)

Accession: 057504013

Download citation: RISBibTeXText

PMID: 26908761

DOI: 10.1093/ndt/gfv462


Related references

Effect of suiphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy. Nephrology Dialysis Transplantation 11(1): 182-185, 1996

Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy. Nephrology, Dialysis, Transplantation 11(1): 182-185, 1996

Phosphodiesterase Type 5 Inhibition Reduces Albuminuria in Subjects with Overt Diabetic Nephropathy. Journal of the American Society of Nephrology 27(11): 3459-3468, 2016

Effect of PF-04634817, an Oral CCR2/5 Chemokine Receptor Antagonist, on Albuminuria in Adults with Overt Diabetic Nephropathy. Kidney International Reports 3(6): 1316-1327, 2018

Effects of diet-therapy on urinary protein excretion albuminuria and renal haemodynamic function in obese diabetic patients with overt nephropathy. International Journal of Obesity 13(2): 203-211, 1989

Determination of albuminuria in type 1 and type 2 diabetic patients with microproteinuria and overt nephropathy comparative evaluation between a radial immunodiffusion procedure and a highly sensitive radioimmunoassay. Ricerca in Clinica e in Laboratorio 17(2): 171-179, 1987

The telmisartan renoprotective study from incipient nephropathy to overt nephropathy--rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, Investigation on Type 2 Diabetic Nephropathy (INNOVATION) Study. Journal of International Medical Research 33(6): 677-686, 2005

Progression of overt diabetic nephropathy Role of metabolic control. Journal of the American Society of Nephrology 6(3): 453, 1995

Determination of albuminuria in the urine of diabetics for prevention and control of diabetic nephropathy. Gms Health Technology Assessment 1: Doc04, 2005

Does smoking increase the risk of progression of nephropathy and/or cardiovascular disease in type 2 diabetic patients with albuminuria and those without albuminuria?. American Journal of Cardiovascular Disease 6(2): 66-69, 2016

Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial. Journal of the American Society of Nephrology 12(2): 333-340, 2001

Strict blood pressure control reduces urinary protein excretion in patients with overt diabetic nephropathy. Journal of the Japan Diabetes Society 50(3): 191-196, 2007

Nephropathy in siblings of African Americans with overt type 2 diabetic nephropathy. American Journal of Kidney Diseases 40(3): 489-494, 2002

Effect of antihypertensive combinations on arterial pressure, albuminuria, and glycemic control in patients with type II diabetic nephropathy: a randomized study. Nefrologia 22(2): 170-178, 2002

Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. Annals of Internal Medicine 138(7): 542-549, 1 April, 2003